| Shannon Lyn Young, | |
|
1811 Winchester Dr Apt 4, Elko, NV 89801-8330 | |
| (775) 388-4508 | |
| Not Available |
| Full Name | Shannon Lyn Young |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1811 Winchester Dr Apt 4, Elko, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962983189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Lyn Young, 1811 Winchester Dr Apt 4, Elko, NV 89801-8330 Ph: (775) 388-4508 | Shannon Lyn Young, 1811 Winchester Dr Apt 4, Elko, NV 89801-8330 Ph: (775) 388-4508 |
News Archive
A new study from Keith Baar's Functional Molecular Biology Laboratory at the UC Davis College of Biological Sciences and the Australian Institute of Sport suggests that consuming a gelatin supplement, plus a burst of intensive exercise, can help build ligaments, tendons and bones.
There has been much uncertainty regarding the risk of cancer associated with taking hormone replacement therapy (HRT) for the menopause. An analysis of all available evidence published in The Lancet today shows that HRT, even when taken for only a few years, significantly increases the risk of developing the two most common types of ovarian cancer.
Vaginal delivery for early preterm fetuses presenting head first, or vertex presentation, had a high rate of success with no difference in neonatal mortality compared to cesarean delivery, a new study published in the American Journal of Obstetrics and Gynecology reports. For breech births, however, the failure rate of vaginal delivery was high and planned cesarean delivery was associated with significantly lower neonatal mortality.
KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers with KP201, its novel abuse deterrent prodrug of hydrocodone for pain. KP201 is a new chemical entity and is the most advanced opioid-based lead candidate in KemPharm's emerging pipeline.
Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.
› Verified 3 days ago
Mr. Jeffrey D Osmonson, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 174 Idaho St, Elko, NV 89801 Phone: 775-777-9548 Fax: 775-753-5457 | |
Jared Smith, BA, MS, CADC-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 3740 E Idaho St, Elko, NV 89801 Phone: 775-738-8004 | |
Sherry Lynn Taylor, CADC-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 215 Bluffs Ave Ste 100, Elko, NV 89801 Phone: 775-777-8477 | |
Mr. Christian Anderson, CPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 380 Court St, Elko, NV 89801 Phone: 915-779-5600 | |
Michelle Miller, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1825 Pinion Rd, Elko, NV 89801 Phone: 775-738-8021 | |
Maria Carmen Martin, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3740 E Idaho St, Elko, NV 89801 Phone: 775-738-8004 Fax: 775-738-2625 | |
Mr. Jeff R Binger, CADC #00194 Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Youth Center Road, Elko, NV 89803 Phone: 775-738-7182 Fax: 775-738-8812 |